Target intelligence / Profile preview

Gastrointestinal Processes

Molecular classification
Other
01

Overview

Gastrointestinal processes encompass the integrated physiological activities of the alimentary canal, including ingestion, motility, secretion, digestion, absorption, and defecation. These functions are coordinated by a complex network involving the enteric nervous system (ENS), the central nervous system, and a variety of endocrine and paracrine signaling molecules (NIH, 2023). Pathological disruptions in these processes manifest as diverse clinical conditions, ranging from functional disorders like irritable bowel syndrome (IBS) to organic diseases such as Crohn's disease or peptic ulcers (StatPearls, 2023). While the term itself represents a broad physiological category rather than a discrete molecular target, it serves as the functional context for numerous drug classes. Therapeutic agents often target specific components within these processes, such as H2-receptor antagonists for acid control or mu-opioid receptor agonists for motility regulation, to restore homeostasis or alleviate symptoms (PubChem, 2024). Additionally, the gut microbiome plays a critical role in these processes, influencing both local metabolism and systemic immune responses.

Other names
DigestionGastrointestinal functionGI motilityAlimentary processesDigestive processes
02

Mechanism of action

Pharmacological agents modulate gastrointestinal processes by acting on specific molecular targets such as the H+/K+ ATPase enzyme to inhibit acid secretion, serotonin receptors (5-HT3 or 5-HT4) to alter motility, or chloride channels to promote fluid secretion (PubChem, 2024).

03

Biological functions

DigestionNutrient absorptionGastrointestinal motilityGastric acid secretionImmune surveillanceWaste elimination
04

Disease associations

Gastroesophageal reflux disease (GERD)Inflammatory bowel disease (IBD)Irritable bowel syndrome (IBS)GastroparesisPeptic ulcer disease
05

Safety considerations

Electrolyte disturbancesAltered drug absorptionGut microbiome dysbiosisIncreased risk of enteric infections (e.g., C. difficile)Gastrointestinal perforation
06

Interacting drugs

Omeprazole

6 more in the full profile.

07

Biomarkers

Fecal calprotectinSerum gastrinC-reactive protein (CRP)Hydrogen breath testGastric pH

Beyond the preview

Go deeper on Gastrointestinal Processes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastrointestinal Processes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call